An investigation for current long-term investors in shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) over potential wrongdoing by certain officers and directors of Progenics Pharmaceuticals was announced and current long-term NASDAQ:PGNX ...

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Progenics Pharmaceuticals, Inc. ("Progenics" or the "Company") (NasdaqGS: PGNX) for ...

TARRYTOWN, May 17, 2013 (GLOBE NEWSWIRE via COMTEX) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index effective prior to market open on Monday, May ...

Progenics Pharmaceuticals, Inc. discovers and develops innovative medicines for oncology, with a pipeline that includes product candidates in preclinical through late-stage development.

Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) shares increased 10.70% to $4.76. The company on May 10 announced its results of operations for the quarter ended March 31.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose 19.64% to $6.58 and ranged between $6.00 and $7.23 after its price target was raised to $17 from $11 at Lazard Capital.

Headquartered on the Landmark at Eastview life sciences campus, Progenics Pharmaceuticals Inc. develops drugs for oncology.

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) is a biopharmaceutical company focused on the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening ...

Progenics in January acquired Molecular Insight Pharmaceuticals Inc., a clinical-stage private biotechnology company headquartered in Cambridge, Mass., in an all-stock transaction. The Massachusetts company has a development pipeline of targeted ...

... Therapeutics, Inc. (Nasdaq:HPTX); NewLink Genetics Corporation (Nasdaq:NLNK); Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX); Repligen Corporation (Nasdaq:RGEN); Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP); and Synergy Pharmaceuticals, ...